Literature DB >> 25415642

Utility Analysis of Vision-related Quality of Life in Patients With Glaucoma and Different Perceptions from Ophthalmologists.

Shaodan Zhang1, Yuanbo Liang, Yanyun Chen, David C Musch, Chun Zhang, Ningli Wang.   

Abstract

PURPOSE: To evaluate patient-perceived quality of life with glaucoma and to assess whether ophthalmologists fully appreciate patients' perceptions through utility analysis. PATIENTS AND METHODS: Utility values were obtained from 87 glaucoma patients by linear rating scale (RS), standard gamble for blindness (SG), and time trade-off (TTO) methods. Identical questionnaires were delivered to ophthalmologists (n=26) at the same center, who were asked to assume they had mild (MD in better-seeing eye ≥-6 dB) or moderate to severe (MD in better-seeing eye <-6 dB) glaucoma. Responses from patients and ophthalmologists were compared.
RESULTS: Patients with mild glaucoma gave a utility value of 0.70±0.14, 0.85±0.14, and 0.77±0.14 with RS, SG, and TTO method, respectively. Those with moderate to severe glaucoma generated corresponding utilities of 0.56±0.20, 0.75±0.20, and 0.78±0.11. RS and SG utilities were affected by disease severity and history of glaucoma surgery, whereas TTO utility was mainly related with education level and employment status of the patients. Ophthalmologists reported higher utility values than their patients when mild glaucoma was assumed (0.81±0.14, 0.96±0.05, and 0.95±0.05 for RS, SG, and TTO methods, respectively; P<0.05). Given the scenario of moderate to severe glaucoma, ophthalmologists gave significantly lower RS (0.35±0.21, P<0.001), but similar SG (0.74±0.27, P=0.84) and TTO (0.82±0.13, P=0.40) utility values, than the patients.
CONCLUSIONS: Utility values are considerably decreased in Chinese patients with glaucoma. Ophthalmologists tend to substantially underestimate the impact of mild glaucoma on patients' quality of life. Better understanding patients' perceptions of glaucoma would be helpful for the establishment of shared decision making and patient-centered care.

Entities:  

Mesh:

Year:  2015        PMID: 25415642     DOI: 10.1097/IJG.0000000000000056

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  4 in total

1.  Cost-Utility Analysis of Glaucoma Medication Adherence.

Authors:  Paula Anne Newman-Casey; Mariam Salman; Paul P Lee; Justin D Gatwood
Journal:  Ophthalmology       Date:  2019-10-10       Impact factor: 12.079

2.  Validation of the Glaucoma Quality of Life-15 Questionnaire in Serbian language.

Authors:  Ivan Sencanic; Tatjana Gazibara; Jelena Dotlic; Miroslav Stamenkovic; Vesna Jaksic; Marija Bozic; Anita Grgurevic
Journal:  Int J Ophthalmol       Date:  2018-10-18       Impact factor: 1.779

3.  Utility Index and Patient-Reported Outcome Measures in Glaucomatous Patients Comparing with Normal Participants.

Authors:  Kulawan Rojananuangnit; Nuttawan Sudjinda
Journal:  Clin Ophthalmol       Date:  2021-02-25

4.  Assessment of online patient education materials designed for people with age-related macular degeneration.

Authors:  Jennifer Fortuna; Anne Riddering; Linda Shuster; Cassie Lopez-Jeng
Journal:  BMC Ophthalmol       Date:  2020-10-02       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.